[HTML][HTML] Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma

…, MO Saavedra, CC Cantu, P Yerramilli… - The American journal of …, 2020 - Elsevier
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …

[HTML][HTML] Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas

…, R Mangham, S Pena, T Trinh, P Yerramilli… - The American journal of …, 2022 - Elsevier
Genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have
repeatedly altered the course of the coronavirus disease 2019 (COVID-19) pandemic. Delta …

Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area

…, M Shukla, M Nguyen, MO Saavedra, P Yerramilli… - MBio, 2020 - Am Soc Microbiol
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
strains causing two coronavirus disease 2019 (COVID-19) disease waves in …

[HTML][HTML] Sequence analysis of 20,453 severe acute respiratory syndrome coronavirus 2 genomes from the Houston metropolitan area identifies the emergence and …

…, R Olson, JJ Davis, MO Saavedra, P Yerramilli… - The American journal of …, 2021 - Elsevier
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, there has been international concern about the emergence of virus variants with …

Treatment of COVID-19 patients with convalescent plasma in Houston, Texas

…, GC Ippolito, MO Saavedra, CC Cantu, P Yerramilli… - medRxiv, 2020 - medrxiv.org
Background COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent …

[HTML][HTML] Trajectory of growth of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in Houston, Texas, January through May 2021, based on …

…, R Olson, M Nguyen, JJ Davis, P Yerramilli… - The American Journal of …, 2021 - Elsevier
Certain genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are of substantial concern because they may be more transmissible or detrimentally alter the …

Population genomic molecular epidemiological study of macrolide-resistant Streptococcus pyogenes in Iceland, 1995 to 2016: identification of a large clonal …

…, G Haraldsson, P Yerramilli… - Journal of clinical …, 2020 - Am Soc Microbiol
Resistance to macrolide antibiotics is a global concern in the treatment of Streptococcus
pyogenes (group A Streptococcus [GAS]) infections. In Iceland, since the detection of the first …

Sequence analysis of 20,453 SARS-CoV-2 genomes from the Houston Metropolitan Area identifies the emergence and widespread distribution of multiple isolates of …

…, R Olson, JJ Davis, MO Saavedra, P Yerramilli… - MedRxiv, 2021 - medrxiv.org
Since the beginning of the SARS-CoV-2 pandemic, there has been international concern
about the emergence of virus variants with mutations that increase transmissibility, enhance …

New pathogenesis mechanisms and translational leads identified by multidimensional analysis of necrotizing myositis in primates

…, RJ Olsen, L Zhu, SL Kubiak, L Pruitt, P Yerramilli… - MBio, 2020 - Am Soc Microbiol
A fundamental goal of contemporary biomedical research is to understand the molecular
basis of disease pathogenesis and exploit this information to develop targeted and more-…

Functional insights into the high-molecular-mass penicillin-binding proteins of Streptococcus agalactiae revealed by gene deletion and transposon mutagenesis …

L Zhu, P Yerramilli, L Pruitt, A Mishra… - Journal of …, 2021 - Am Soc Microbiol
High-molecular-mass penicillin-binding proteins (PBPs) are enzymes that catalyze the
biosynthesis of bacterial cell wall peptidoglycan. The Gram-positive bacterial pathogen …